Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000617908 | SCV000737667 | likely benign | Cardiovascular phenotype | 2016-10-19 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Invitae | RCV000631830 | SCV000752926 | benign | Long QT syndrome | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV001841802 | SCV001346443 | benign | Cardiac arrhythmia | 2018-10-22 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001613408 | SCV001834517 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002477352 | SCV002803670 | likely benign | Short QT syndrome type 1; Long QT syndrome 2 | 2021-07-29 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV001613408 | SCV004564238 | benign | not provided | 2023-08-31 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV000631830 | SCV004835873 | benign | Long QT syndrome | 2024-02-05 | criteria provided, single submitter | clinical testing | |
Clinical Genetics, |
RCV001700253 | SCV001920677 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001613408 | SCV001958857 | likely benign | not provided | no assertion criteria provided | clinical testing |